Reporting owner · CIK 0001660683

Biotechnology Value Trading Fund OS LP

Visual SEC Form 4 history across 4 companies, 17 transactions and 4 filings.

DIRIMMUNIC, INC.
Open-market mix
Latest filingSep 18, 2026, 11:45 PM
Filings4Form 4 records
Buying$00 purchases
Selling$17M4 sales
Net value−$17MBuys minus sells
Companies45 securities
Most recentSep 16, 2026grant

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-54Jan 25Jan 26Sep 26

Net value flow

Buys minus sells

Jan 25
−$17M
Jan 26
$0
Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$4.2M
Median P/S size$3.1M
Direct15
Indirect2
Sep 16, 2026grant

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern4Derivative Transactionfiling-context3Direct Ownershipfiling-context15Large Salesize4Repeat Sellerpattern3

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at XOMA Royalty Corp on Jan 24, 2025 valued at $3,914,348.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at XOMA Royalty Corp on Jan 24, 2025 valued at $3,914,348.

Review SEC filing

Associated companies

Visual map of known reporting history

IMUXIMMUNIC, INC.1 transactions · latest Sep 18, 2026, 11:45 PMRPTXRepare Therapeutics Inc.6 transactions · latest Jan 30, 2026, 12:00 AMXOMAXOMA Royalty Corp4 transactions · latest Jan 28, 2025, 10:23 PMOLMAOlema Pharmaceuticals, Inc.6 transactions · latest Jan 14, 2025, 11:38 PM

Latest insider transactions

Form 4 filings from available history. Click any column to sort; click it again to flip the order.

Biotechnology Value Trading Fund OS LP transactions
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#52831XOMABiotechnology Value Trading Fund OS LP
SER
sale339k-$886MS01/28/202501/24/2025
#32804OLMABiotechnology Value Trading Fund OS LP
DIR
grant22.7k—A01/14/202501/10/2025
#32803OLMABiotechnology Value Trading Fund OS LP
DIR
grant161k—A01/14/202501/10/2025
#32802OLMABiotechnology Value Trading Fund OS LP
DIR
grant235k—A01/14/202501/10/2025
#32801OLMABiotechnology Value Trading Fund OS LP
DIR
return22.7k—D01/14/202501/10/2025
#32800OLMABiotechnology Value Trading Fund OS LP
DIR
return161k—D01/14/202501/10/2025
#32799OLMABiotechnology Value Trading Fund OS LP
DIR
return235k—D01/14/202501/10/2025

Biotechnology Value Trading Fund OS LP Insider Activity FAQ

SEC Form 4 context

Who is Biotechnology Value Trading Fund OS LP?

Biotechnology Value Trading Fund OS LP is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001660683.

Which companies has Biotechnology Value Trading Fund OS LP reported transactions for?

IMMUNIC, INC., Repare Therapeutics Inc., XOMA Royalty Corp, Olema Pharmaceuticals, Inc.

When was Biotechnology Value Trading Fund OS LP's latest insider buy?

No open-market insider purchase is available for this period.

When was Biotechnology Value Trading Fund OS LP's latest insider sale?

sale at XOMA Royalty Corp on Jan 24, 2025 valued at $3,914,348.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.